Clinical trial
Combination Chemotherapy With or Without Biological Therapy in Treating Patients…
NCT00005021 · Fox Chase Cancer Center, Other · Completed
Key facts
| NCT number | NCT00005021 |
|---|---|
| Title | Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma |
| Official title | Phase I Evaluation of Topotecan in Combination With Paclitaxel and Carboplatin |
| Lead sponsor | Fox Chase Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lymphoma, Small Intestine Cancer, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Biological, Drug |
| Interventions | filgrastim, carboplatin, paclitaxel, topotecan hydrochloride |
| Enrollment | 17 |
| Start date | Jul 1, 1996 |
| Primary completion | May 1, 2003 |
| Completion | May 1, 2003 |
| First posted | May 3, 2004 |
| Last update posted | Jul 11, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: